Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04935606 · ClinicalTrials.gov registry record · NA
mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care
A NA study of Drug Use, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 458
- Enrollment target
- 5
- Study locations
NCT04935606 is a NA study of Drug Use that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 458 participants, above the 205-participant average among 25 other Drug Use trials with a reported enrollment target (123% higher). The trial reports 5 study locations across 1 state.
The verdict
NCT04935606, a NA study of Drug Use, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 458 participants
- Enrollment target
- 5
- Study locations
Study Summary
The QUIT-Mobile study proposes to use mobile phone self-monitoring and feedback to enhance and sustain over 12-months the impacts of the Quit Using Drugs Intervention Trial (QUIT), an effective screening and brief intervention (SBI) previously successful in reducing risky drug use (i.e., moderate use) in low-income, diverse patients over a 3-month follow up. The investigators will conduct the QUIT-Mobile study for patients who receive care in clinics of federally qualified health centers (FQHC) in Southern California over 12-months follow up. The study is an Effectiveness-Implementation Hybrid Type 1 design consisting of a single-blind, 3-arm, RCT with adult, mostly Latino FQHC primary care patients with risky drug use (ASSIST score 4-26), randomized to 3 conditions (n=200/arm, n=600 total): 1) QUIT-Mobile; 2) standard QUIT; 3) Usual Care. Qualitative data on implementation facilitators and barriers will inform future scale-up and sustainability, in addition to cost data analyses. The aims are to examine effectiveness in reducing risky drug use and cost-effectiveness comparing the three arms over 3-, 6- and 12-months. Drug use measures include self-reports for past 30-days and urine drug screen validation for underreporting (acknowledging that people with moderate risk drug use have sporadic drug use patterns requiring longer self-report recalls for drug use that urine screens may not detect). The 3-arm study enables testing of the independent and synergistic effects of QUIT-Mobile compared to QUIT and both to Usual Care. The 12-month timeline reflects annual primary care visits when screening and brief intervention would be repeated routinely. The QUIT intervention contains 3 primary components: 1) patient screening with the WHO ASSIST, 2) brief clinician advice (\<3 minutes) including opioid overdose prevention education, and 3) 2- and 6-week telephone drug-use health coaching sessions utilizing motivational interviewing and cognitive behavioral techniques, del
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks)
- BEHAVIORAL QUIT-Mobile (QUIT Intervention plus weekly mobile-web app or text message weekly self-monitoring, automated feedback over 12 months)
Study Locations (5)
California
- The Children's Clinic (TCC) Family Health - Long Beach
- South Central Family Health Clinic - Los Angeles
- Wesley Health Centers - Los Angeles
- Saban Community Clinic - Los Angeles
- UMMA Community Clinic - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 458 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04935606
The ClinicalTrials.gov registry entry for NCT04935606 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 458 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 205-participant average among 25 other Drug Use trials with a reported enrollment target (123% higher). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Drug Use appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.
NCT04935606 reports 5 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04935606 about?
NCT04935606 is a clinical study titled "mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care". The QUIT-Mobile study proposes to use mobile phone self-monitoring and feedback to enhance and sustain over 12-months the impacts of the Quit Using Drugs Intervention Trial (QUIT), an effective screening and brief intervention (SBI) previously successful in reducing risky drug use (i.e., moderate us...
What is the current status of trial NCT04935606?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 458 participants. The study started on 2021-06-01. Estimated completion is 2026-03-31.
What conditions does trial NCT04935606 study?
This clinical trial studies the following conditions: Drug Use.
What interventions are being tested in trial NCT04935606?
The interventions under investigation include: Usual Care (BEHAVIORAL), QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks) (BEHAVIORAL), QUIT-Mobile (QUIT Intervention plus weekly mobile-web app or text message weekly self-monitoring, automated feedback over 12 months) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04935606?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04935606 being conducted?
This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Families With Pride ("Familias Con Orgullo").
RECRUITING · NA
-
Lakota Family Acceptance Project
RECRUITING · NA
-
Mental Health in Primary Care
RECRUITING · NA
-
Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents
RECRUITING · NA
-
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
RECRUITING · NA
-
Harm Reduction Services
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.